Neuropathix, Inc. NPTX Stock
Neuropathix, Inc. Price Chart
Neuropathix, Inc. NPTX Financial and Trading Overview
| Neuropathix, Inc. stock price | 0.0003 USD |
| Previous Close | 0.0003 USD |
| Open | 0.0003 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0003 - 0.0003 USD |
| 52 Week Range | 0.0002 - 0.04 USD |
| Volume | 10K USD |
| Avg. Volume | 13.57K USD |
| Market Cap | 28.14K USD |
| Beta (5Y Monthly) | 1.746517 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NPTX Valuation Measures
| Enterprise Value | 2.04M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.07829309 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.663 |
| Enterprise Value/EBITDA | -0.925 |
Trading Information
Neuropathix, Inc. Stock Price History
| Beta (5Y Monthly) | 1.746517 |
| 52-Week Change | -98.92% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.0002 USD |
| 50-Day Moving Average | 0.0003 USD |
| 200-Day Moving Average | 0.00562505 USD |
NPTX Share Statistics
| Avg. Volume (3 month) | 13.57K USD |
| Avg. Daily Volume (10-Days) | 1.25K USD |
| Shares Outstanding | 93.81M |
| Float | 36.59M |
| Short Ratio | N/A |
| % Held by Insiders | 23.54% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | March 31, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -618.47% |
| Gross Margin | -51.031% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -308.10% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 359.46K USD |
| Revenue Per Share (ttm) | 0.004 USD |
| Quarterly Revenue Growth (yoy) | 549.89% |
| Gross Profit (ttm) | -268302 USD |
| EBITDA | -2201011 USD |
| Net Income Avi to Common (ttm) | -3824817 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 102.19K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 2.11M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.03 |
| Book Value Per Share (mrq) | -0.056 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -557434 USD |
| Levered Free Cash Flow (ttm) | 600.96K USD |
Profile of Neuropathix, Inc.
| Country | United States |
| State | PA |
| City | Doylestown |
| Address | 3805 Old Easton Road |
| ZIP | 18902 |
| Phone | 858 883 2642 |
| Website | https://neuropathix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform. It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. The company was formerly known as Kannalife, Inc. and changed its name to Neuropathix, Inc. in November 2020. Neuropathix, Inc. was founded in 2010 and is based in Doylestown, Pennsylvania.
Q&A For Neuropathix, Inc. Stock
What is a current NPTX stock price?
Neuropathix, Inc. NPTX stock price today per share is 0.0003 USD.
How to purchase Neuropathix, Inc. stock?
You can buy NPTX shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neuropathix, Inc.?
The stock symbol or ticker of Neuropathix, Inc. is NPTX.
Which industry does the Neuropathix, Inc. company belong to?
The Neuropathix, Inc. industry is Biotechnology.
How many shares does Neuropathix, Inc. have in circulation?
The max supply of Neuropathix, Inc. shares is 93.81M.
What is Neuropathix, Inc. Price to Earnings Ratio (PE Ratio)?
Neuropathix, Inc. PE Ratio is 0.00000000 now.
What was Neuropathix, Inc. earnings per share over the trailing 12 months (TTM)?
Neuropathix, Inc. EPS is 0 USD over the trailing 12 months.
Which sector does the Neuropathix, Inc. company belong to?
The Neuropathix, Inc. sector is Healthcare.